WWP1 deficiency protects from cardiac remodeling induced by simulated microgravity

Guohui Zhong, Zhao Dingsheng, Jianwei Li, Zifan Liu, Junjie Pan, Xinxin Yuan, Wenjuan Xing, Yinglong Zhao, Shukuan Ling, Yingxian LibioRxiv 2021 · DOI

TL;DR

This study reveals that the E3 ubiquitin ligase WWP1 plays a critical role in microgravity-induced cardiac remodeling. By knocking out WWP1, researchers protected mice from cardiac atrophy and functional decline caused by simulated microgravity, suggesting WWP1 as a potential therapeutic target for spaceflight-related cardiovascular issues.

What Problem Does This Paper Address?

Spaceflight, and the resulting microgravity, poses significant risks to astronaut health, particularly affecting the cardiovascular system. Cardiac muscle is highly sensitive to changes in loading conditions, and microgravity can lead to cardiac remodeling and a decline in function. While the mechanisms behind this remodeling are not fully understood, previous research has implicated WWP1 in pressure-overload-induced cardiac remodeling by stabilizing DVL2 and activating the CaMKII/HDAC4/MEF2C pathway. However, WWP1's specific role in microgravity-induced cardiac remodeling remained unknown, creating a knowledge gap that this study aims to fill.

Methods

The researchers employed a multi-pronged approach to investigate WWP1's role:

  • Simulated Microgravity Models: They used two primary models:
  • Hindlimb Unloading (HU) in Mice: This standard technique involves suspending mice by their hindlimbs at a 30-degree angle, simulating the unloading experienced in microgravity.
  • Bed Rest in Rhesus Monkeys: This model mimics prolonged inactivity and reduced loading conditions.
  • Molecular and Cellular Analysis:
    • Western Blotting and Immunohistochemistry: Used to measure protein levels of WWP1 and DVL2 in heart tissues from both mice and monkeys under simulated microgravity conditions.
  • Histological Analysis (H&E, Masson's Trichrome, WGA staining): Examined cardiac tissue morphology, fibrosis, and cardiomyocyte size to assess structural changes.
  • Quantitative Polymerase Chain Reaction (Q-PCR): Measured the expression levels of cardiac remodeling-related genes (BNP, Col1a1, Col3a1).
  • Functional Assessment:
    • Echocardiography: Performed to assess cardiac function, including ejection fraction (EF) and fractional shortening (FS), as well as left ventricular structure (wall thickness, internal dimensions, and volume).
  • Genetic Manipulation:
    • WWP1 Knockout (KO) Mice: Utilized genetically modified mice lacking WWP1 to determine its specific contribution to microgravity-induced cardiac changes.

Datasets

Not discussed in the paper. The study relies on experimental data generated from animal models.

Key Insights and Ideas

  • WWP1 is Upregulated by Microgravity: The study found that WWP1 protein levels significantly increase in the hearts of both mice and monkeys exposed to simulated microgravity. This suggests WWP1 is a key player in the heart's response to these conditions.
  • WWP1 Deficiency is Protective: Crucially, knocking out WWP1 protected mice from the negative effects of simulated microgravity, including cardiac atrophy and functional decline. This is a strong indicator that WWP1 is a detrimental factor in this context.
  • DVL2 is Linked to WWP1 in Microgravity: The study confirmed a positive correlation between WWP1 and DVL2 protein levels under simulated microgravity, reinforcing their previously established relationship in pressure-overload hypertrophy and suggesting a conserved mechanism.
  • The DVL2/CaMKII/HDAC4 Axis is Involved: The research demonstrated that WWP1 regulates cardiac remodeling via the DVL2/CaMKII/HDAC4 pathway, even in the context of microgravity. WWP1 knockout mice showed attenuated activation of this pathway.

Key Results

  • Increased WWP1 and DVL2: Simulated microgravity led to significantly increased protein levels of WWP1 and DVL2 in the hearts of both mice and monkeys.
  • Protection by WWP1 KO: WWP1 knockout mice showed preserved cardiac function (EF and FS) and reduced cardiac atrophy (indicated by stable heart weight to tibia length ratio) compared to wild-type mice after hindlimb unloading.
  • Inhibition of Cardiomyocyte Size Reduction: Histological analysis revealed that WWP1 knockout prevented the decrease in cardiomyocyte size observed in wild-type mice under simulated microgravity.
  • Reduced Cardiac Remodeling Gene Expression: In WWP1 KO mice, the upregulation of cardiac remodeling genes (BNP, Col1a1, Col3a1) seen in wild-type mice after hindlimb unloading was attenuated.
  • Pathway Modulation: WWP1 knockout inhibited the increased phosphorylation of CaMKII and HDAC4, key components of the DVL2/CaMKII/HDAC4 signaling pathway, in response to simulated microgravity.

Limitations and Future Work

  • Limitations:
    • The study primarily uses simulated microgravity models (hindlimb unloading and bed rest). While these are valuable, they do not perfectly replicate the complex environment of actual spaceflight.
  • The study focuses on the acute and sub-chronic effects of simulated microgravity. The long-term consequences and potential for adaptation or recovery are not fully explored.
  • Future Work:
    • The authors suggest that WWP1 represents a potential therapeutic target for mitigating microgravity-induced cardiac remodeling and function decline. Future research could focus on developing and testing pharmacological interventions that target WWP1.
  • Investigating the precise molecular mechanisms by which WWP1 influences DVL2 stability and the downstream signaling cascade in the context of microgravity could provide further insights.
  • Exploring the role of WWP1 in other organ systems affected by spaceflight could reveal broader implications.

Summary updated

Abstract

Abstract Cardiac muscle is extremely sensitive to changes in loading conditions, the microgravity during space flight can cause cardiac remodeling and function decline. At present, the mechanism of microgravity-induced cardiac remodeling remains to be revealed. WW domain-containing E3 ubiquitin protein ligase 1 (WWP1) is an important activator of pressure-overload induced cardiac remodeling by stabilizing disheveled segment polarity proteins 2 (DVL2) and activating CaMKII/HDAC4/MEF2C axis. However, the role of WWP1 in the cardiac remodeling induced by microgravity is unknown. The purpose of this study was to determine whether WWP1 was also involved in the regulation of cardiac remodeling caused by microgravity. Firstly, we detected the expression of WWP1 and DVL2 in the heart from mice and monkeys after simulated microgravity using western blotting and Immunohistochemistry. Secondly, WWP1 knockout (KO) and wild type mice were subjected to hindlimb unloading (HU) to simulate microgravity effect. We assessed the cardiac remodeling in morphology and function through histological analysis and echocardiography. Finally, we detected the phosphorylation level of CaMKII and HDAC4 in the heart from WT and WWP1 KO mice after HU. The results revealed the increased expression of WWP1 and DVL2 in the heart both from mice and monkey after simulated microgravity. WWP1 deficiency protected against simulated microgravity-induced cardiac atrophy and function decline. Histological analysis demonstrated WWP1 KO inhibited the decreases in the size of individual cardiomyocytes of mice after hindlimb unloading. WWP1 KO can inhibit the activation of DVL2/CaMKII/HDAC4 pathway in heart of mice induced by simulated microgravity. These results demonstrated WWP1 as a potential therapeutic target for cardiac remodeling and function decline induced by simulated microgravity.
BibTeX
@misc{zhong2021wwp,
  author = {Guohui Zhong and Zhao Dingsheng and Jianwei Li and Zifan Liu and Junjie Pan and Xinxin Yuan and Wenjuan Xing and Yinglong Zhao and Shukuan Ling and Yingxian Li},
  title = {{WWP1 deficiency protects from cardiac remodeling induced by simulated microgravity}},
  year = {2021},
  doi = {10.1101/2021.06.18.447041},
  howpublished = {bioRxiv},
}
Figure